Lotus Pharm vs LI Kang Biomedical: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and LI Kang Biomedical (6242) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ LI Kang Biomedical

0%+226%-45%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYLI Kang BiomedicalYoY
Oct 2026NT$2.13 billion-22.5%NT$53 million-8.1%
Sep 2026NT$2.77 billion+128.0%NT$41.9 million+7.6%
Aug 2026NT$2.11 billion+81.7%NT$37 million-0.5%
Jul 2026NT$2.49 billion+3.9%NT$42.1 million-0.1%
Jun 2026NT$3.4 billion+225.5%NT$49.9 million-8.3%
May 2026NT$2.32 billion+105.8%NT$58 million+7.9%
Apr 2026NT$3.09 billion+19.9%NT$54.1 million-4.2%
Mar 2026NT$4.35 billion+173.6%NT$53.5 million-7.9%
Feb 2026NT$2.24 billion+131.5%NT$24.4 million-44.6%
Jan 2026NT$2.05 billion-5.5%NT$43.7 million+33.6%
Dec 2025NT$2.44 billion+66.9%NT$54.8 million+3.3%
Nov 2025NT$1.06 billion-0.2%NT$59.2 million+10.2%
Oct 2025NT$2.75 billion+46.0%NT$57.6 million+0.8%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16